-
Signature
-
/s/ Hannah Valantine
-
Stock symbol
-
BBIO
-
Transactions as of
-
Jun 10, 2025
-
Transactions value $
-
-$99,789
-
Form type
-
4
-
Date filed
-
6/11/2025, 05:00 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Valantine Hannah |
Director |
C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO |
/s/ Hannah Valantine |
2025-06-11 |
0001855608 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BBIO |
Common Stock |
Options Exercise |
$71.9K |
+4.29K |
+243.31% |
$16.75 |
6.06K |
Jun 10, 2025 |
Direct |
F1 |
| transaction |
BBIO |
Common Stock |
Sale |
-$172K |
-4.29K |
-70.87% |
$40.00 |
1.76K |
Jun 10, 2025 |
Direct |
F1 |
| holding |
BBIO |
Common Stock |
|
|
|
|
|
3.43K |
Jun 10, 2025 |
By Spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BBIO |
Stock Option (right to buy) |
Options Exercise |
$0 |
-4.29K |
-11.11% |
$0.00 |
34.3K |
Jun 10, 2025 |
Common Stock |
4.29K |
$16.75 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: